Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michel‐Olivier Gratton
Molecular Monitoring of Therapeutic Milestones and Clinical Outcomes in Patients With Chronic Myeloid Leukemia
Cancer
Cancer Research
Oncology
Related publications
Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients
Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib for Patients With Chronic Myeloid Leukemia
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Medication Adherence, Molecular Monitoring, and Clinical Outcomes in Patients With Chronic Myelogenous Leukemia in a Large HMO
Journal of the American Pharmacists Association : JAPhA
Pharmacology
Pharmacy
Does the Frequency of Molecular Monitoring After Tyrosine Kinase Inhibitor Discontinuation Affect Outcomes of Patients With Chronic Myeloid Leukemia?
Cancer
Cancer Research
Oncology
New Tool for Monitoring Molecular Response in Chronic Myeloid Leukemia.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Cost Effectiveness of Therapeutic Drug Monitoring for Imatinib Administration in Chronic Myeloid Leukemia
PLoS ONE
Multidisciplinary
The Effectiveness of Tyrosine Kinase Inhibitors and Molecular Monitoring Patterns in Newly Diagnosed Patients With Chronic Myeloid Leukemia in the Community Setting
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Molecular Monitoring of Residual Disease in Chronic Myeloid Leukemia by Genomic DNA Compared With Conventional mRNA Analysis
Journal of Molecular Diagnostics
Forensic Medicine
Pathology
Molecular Medicine
Effect of Tyrosine Kinase Inhibitor in Patients With Chronic Myeloid Leukemia (Cytogenetic, Molecular Response) in Mosul
Annals of the College of Medicine, Mosul
